Today’s Solutions: April 21, 2024

For people who may not have the option to travel to a medical center to get vaccinated, a company called Ayro has a solution: bring the vaccination to them via an electric vehicle equipped with an ultra-cold freezer.

The vehicle is a modified version of the tiny food trucks you might see at a festival or a college campus, but instead of serving up meals, this mobile vaccination unit is serving up immunity to Covid-19. Ayro’s mobile vaccination unit can be charged via a standard outlet and its freezer and fridge are designed to run on batteries.

Beyond being electric, another benefit of the truck is its small size, which allows it to drive directly into a school gym or a remote indoor vaccination site.

As vaccination efforts ramp up, Ayro is teaming up with distribution partner Element Fleet Management to demonstrate its usefulness to potential customers.

“State, local, and federal entities really can use this to get vaccines in arms faster than they were doing it today,” said Ayro CEO Rod Keller. “We’re not making people come to the vaccine distribution areas as much as we’re bringing the vaccine to where they are.”

Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More